Updated 22 august 2016. This document aims to provide interim guidance on the case definition of GBS and strategies to manage the syndrome, in the context of Zika virus and its potential association with GBS. This document is intended to inform the development of local clinical protocols and health ...policies related to the care of patients with GBS
more
Cochrane Database Syst Rev. 2016 Jul 1; (6): 1–61 -Published online 2016 July 1
This Rapid Advice Guideline updates the Interim Guidance on the “Assessment of infants with microcephaly in the context of Zika virus” published in February 2016 (WHO/ZIKV/MOC/16.3). The recommendations provides guidance on the screening, clinical assessment, neuroimaging, laboratory investigati...on and follow-up of children born to women living in areas of Zika virus transmission. The Guideline summarises the evidence base and rationale in support of the recommendations and expands the scope to address complications beyond microcephaly and what is now referred to as the congenital Zika virus syndrome
more
Review
Journal of Virus Eradication 2016 Jul; 2(3): 156–161.
Published online 2016 Jul 1.
PMCID: PMC4967967
PMID: 27482455
Mission report April 2016
Standard Treatment Guideline
Prevention, Assessment and Management
Zika virus infection: update on the evidence for a causal link to congenital brain abnormalities and Guillain-Barré syndrome
Update 7 September 2016
THELANCETID-D-16-00800 S1473-3099(16)30318-8
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
El documento contiene una breve reseña sobre la situación mundial de la tuberculosis; la tuberculosis como problema de salud pública en el país, que incluye el abordaje del análisis de los determinantes y las inequidades sociales y su impacto en el control de la tuberculosis, la evolución y ma...gnitud de la enfermedad, la resistencia a los fármacos antituberculosis y el análisis en poblaciones de riesgo como la coinfección TB_VIH, trabajadores de salud, personas privadas de libertad entre otros.
more